Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

Autor: Haraldsen, Ira Hebold, Hatlestad-Hall, Christoffer, Marra, Camillo, Renvall, Hanna, Maestú, Fernando, Acosta-Hernández, Jorge, Alfonsin, Soraya, Andersson, Vebjørn, Anand, Abhilash, Ayllón, Victor, Babic, Aleksandar, Belhadi, Asma, Birck, Cindy, Bruña, Ricardo, Caraglia, Naike, Carrarini, Claudia, Christensen, Erik, Cicchetti, Americo, Daugbjerg, Signe, Di Bidino, Rossella, Diaz-Ponce, Ana, Drews, Ainar, Giuffrè, Guido Maria, Georges, Jean, Gil-Gregorio, Pedro, Gove, Dianne, Govers, Tim M., Hallock, Harry, Hietanen, Marja, Holmen, Lone, Hotta, Jaakko, Kaski, Samuel, Khadka, Rabindra, Kinnunen, Antti S., Koivisto, Anne M., Kulashekhar, Shrikanth, Larsen, Denis, Liljeström, Mia, Lind, Pedro, Marcos Dolado, Alberto, Marshall, Serena, Merz, Susanne, Miraglia, Francesca, Montonen, Juha, Mäntynen, Ville, Øksengård, Anne Rita, Olazarán, Javier, Paajanen, Teemu, Peña, José M., Peña, Luis, Peniche, Daniel lrabien, Sanz Perez, Ana, Radwan, Mohamed, Ramírez-Toraño, Federico, Rodríguez-Pedrero, Andrea, Saarinen, Timo, Salas-Carrillo, Mario, Salmelin, Riitta, Sousa, Sonia, Suyuthi, Abdillah, Toft, Mathias, Toharia, Pablo, Tveitstøl, Thomas, Tveter, Mats, Upreti, Ramesh, Vermeulen, Robin J., Vecchio, Fabrizio, Yazidi, Anis, Rossini, Paolo Maria

Externí odkaz: https://hdl.handle.net/11250/3123495

The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models.

Autor: Brinch SA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Amundsen-Isaksen E; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Espada S; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Hammarström C; Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Aizenshtadt A; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Olsen PA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Holmen L; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Høyem M; Department of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Scholz H; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Grødeland G; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Sowa ST; Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland., Galera-Prat A; Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland., Lehtiö L; Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland., Meerts IATM; Symeres, Nijmegen, the Netherlands., Leenders RGG; Symeres, Nijmegen, the Netherlands., Wegert A; Symeres, Nijmegen, the Netherlands., Krauss S; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Waaler J; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Apr 20; Vol. 2 (4), pp. 233-245. Date of Electronic Publication: 2022 Apr 20 (Print Publication: 2022).